Utilisation de la creme EMLA® chez la nouveau-né à terme et prématuré. Étude d'efficacité et de tolérance
Archives de PédiatriePublished 1 November 1995
E Gourrier, Philippe Karoubi, A el Hanache, S. Merbouche, G Mouchnino, S Dhabhi
Citations43
SJR quartileQ2
SJR score0.41
SNIP0.62
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
La creme EMLA est efficace et bien toleree chez les nouveau-nes, y cumpris chez the prematures, a condition d'etre appliquee en petite quantite pas plus d'une fois par jour.
Abstract
EMLA cream is effective and safe in neonates including preterms, when it is applied in a small amount once a day.
Keywords
MedicineHealth Professions
Pediatric Clinics of North AmericaThe Neuroanatomy, Neurophysiology, and Neurochemistry of Pain, Stress, and Analgesia in Newborns and Children
380 Citations1989K.J.S. Anand, Daniel B. Carr
The clinical implications of the development of mature anatomic pathways and neurotransmitters in the "pain system" in the human fetus, neonate, and child and the maintenance of cardiovascular stability and hormonal-metabolic homeostasis in newborns and children undergoing surgery or other forms of stress are described.
DrugsEutectic Lidocaine/Prilocaine Cream
186 Citations1993Micaela M.-T. Buckley, Paul Benfield
Eutectic lidocaine/prilocaine cream 5% is a novel formulation of local anaesthetics that has proven to be effective and well-tolerated in the relief of pain associated with various minor interventions in adults and children.
British Journal of AnaesthesiaINVERSE RELATIONSHIP BETWEEN AGE-DEPENDENT ERYTHROCYTE ACTIVITY OF METHAEMOGLOBIN REDUCTASE AND PRILOCAINE-INDUCED METHAEMOGLOBINAEMIA DURING INFANCY
145 Citations1990Anders Nilsson, G. Engberg +3 more
Although the MetHb concentrations in the infants younger than 3 months were small, the enzyme capacity may be overloaded when EMLA is administered at the same time as other methaemoglobin-inducing agents, and it is concluded that the use of E MLA should be restricted in this age group.
Acta Anaesthesiologica ScandinavicaMethemoglobinemia Associated with a Prilocaine‐Lidocaine Cream and Trimetoprim‐Sulphamethoxazole. A Case Report
141 Citations1985B. Jakobson, Anders Nilsson
A case of moderate methemoglobinemia in an infant treated with trimetoprim‐sulphamethoxazole and a topical mixture of lidocaine and prilocaine is described.
Acta Anaesthesiologica ScandinavicaPlasma concentrations of prilocaine and lidocaine and methaemoglobin formation in infants after epicutaneous application of a 5% lidocaineprilocaine cream (EMLA)
116 Citations1987G. Engberg, K. Danielson +2 more
EMLA can be used safely in infants above 3 months of age provided that the recommendations with regard to dose, application area and time are followed and there are only minor increases in Met‐Hb in a few infants.